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The prion protein (PrPC) is a copper binding cell surface glycoprotein which when misfolded causes
transmissible spongiform encephalopathies. The cooperative binding of Cu2+ to an unstructured
octarepeat sequence within PrPC causes profound folding of this region. The use of NMR to determine
the solution structure of the octarepeat region of PrP with Cu2+ bound has been hampered by the
paramagnetic nature of the Cu2+ ions. Using NMR we have investigated the binding of candidate
diamagnetic replacement ions, to the octarepeat region of PrP. We show that Pd2+ forms diamagnetic
complexes with the peptides HGGG, HGGGW and QPHGGGWGQ with 1 : 1 stoichiometry. The 1H
NMR spectra indicate that these peptides are in slow-exchange between free and bound Pd2+ on the
chemical-shift time-scale. We demonstrate that the Pd–peptide complex forms slowly with a time taken
to reach half-maximal signal of 3 hours. Other candidate metal ions, Ni2+, Pt2+ and Au3+, were
investigated but only the Pd2+ complexes gave resolvable 1H NMR spectra. We have determined the
solution structure of the QPHGGGWGQ–Pd 1 : 1 complex using 71 NOE distance restraints. A
backbone RMSD of 0.30 A˚ was observed over residues 3 to 7 in the final ensemble. The co-ordinating
ligands consist of the histidine imidazole side chain Ne, the amide N of the second and third glycines
with possibly H2O as the fourth ligand. The co-ordination geometry differs markedly from that of the
HGGGW–Cu crystal structure. This survey of potential replacement metal ions to Cu2+ provides
insight into the metal specificity and co-ordination chemistry of the metal bound octarepeats.
Introduction
The prion protein PrPC is a cell surface glyco-protein that is
highly conserved across several phyla and widely expressed in
several cell types, particularly neurons of the central nervous
system where it is GPI anchored largely on the pre-synaptic
membrane.1–3 The misfolding of cellular prion protein is asso-
ciated with fatal neurodegenerative diseases that are collectively
described as spongiform encephalopathies. Prion diseases include
Creutzfeldt–Jacob disease (CJD) in humans, bovine spongiform
encephalopathy (BSE) in cattle and scrapie in sheep. The infectious
agent, which is devoid of nucleic acid, is a proteinous infectious
particle, or ‘prion’.4 Prion diseases are characterized by the
accumulation of an abnormally folded isoform of the cellular
prion protein (PrPC) into the misfolded scrapie isoform (PrPSc),
which is rich in b-sheets.1–3
PrPC contains two distinct structural domains.5–8 The N-
terminal region, residues 23–126, has little defined structure in
the absence of Cu2+ ions7 and has a high degree of main-chain
flexibility9 although some ordering is observed at low pH.10 In
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contrast, the C-terminal domain, residues 121–231, is largely
a-helical.5 The unstructured N-terminal domain contains an
octapeptide sequence, PHGGGWGQ,which is repeated four times
between residues 60–91. This octarepeat region binds four Cu2+
ions cooperatively.11–14 In addition we have recently shown that
two Cu2+ ions bind to a region, outside of the octarepeats, between
residues 90 and 126 where Cu2+ binding is centered at His111 and
His96 and promotes the formation of b-sheet in a region of PrP
vital for prion propagation.15,16
The normal physiological function of the prion protein is
yet to be established but the ability of PrPC to bind Cu2+ in
vivo and in vitro suggests a role in copper homeostasis.17,11 PrPC
undergoes constitutive endocytosis that is dependent on the N-
terminal domain (residues 23–107), and Cu2+ has been suggested
to be either required for, or alter the rate of, internalization
of PrP.18,19 Interestingly, a mutant form of PrP associated with
familial prion disease contains nine additional octarepeats and
fails to undergo copper mediated endocytosis.19 In contrast
recent studies have shown that even in the absence of copper,
mouse PrPC is still rapidly endocytosed.20 Furthermore, PrP
expression levels do not seem to affect copper delivery.21,22 PrPC
expression increases the binding of copper to the outer plasma
cell membrane and increases antioxidant enzyme activities.21 It
is also suggested that PrPC plays a protective role by binding
Cu2+ in a redox inactive state.23,24 An enzymatic role for Cu–
PrP has also been proposed as it exhibits superoxide dismutase
activity.25–28
In prion disease metal binding to the prion protein is altered29
andmetal imbalances are a feature of priondisease.30 PrPSc isolated
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from diseased brain is found to be metal occupied31 and copper
content at a cellular level is modulated by scrapie infection.32
In addition, Cu2+ can convert the cellular prion protein into
a protease-resistant species.33 Different protease profiles of PrP,
observed with and without the presence of Cu2+ ions, correspond
to similar profiles seen in different strains of prion disease.34,31
Copper induced redox damage of PrP is implicated in prion
disease.35,36 In addition, disease progression in infected mice has
been reported to slow with the use of copper specific chelation
therapy.37 The role of copper in prion diseases, as well as in the
normal function of PrP, has been the subject of a number of
reviews.38–43
The precise structure of the N-terminal octameric repeat region
with bound copper has yet to be fully established. However, it
is clear that binding of copper causes the region to undergo
a profound conformational change to a more ordered state.11,12
A crystal structure of the copper bound HGGGW motif has
been reported14 which shows Cu2+ co-ordinated with 3N and 1O
equatorial ligands and an axial water molecule to form a square-
pyramidal geometry. The crystal structure is consistent with the
EPR data suggesting type II co-ordination geometry.11,13 The EPR
spectra ofCu–HGGGWare indistinguishable from largermultiple
repeats11,13 and so represent the co-ordination of Cu2+ to a full
single octarepeat. However, the crystal structure of HGGGW
does not explain the co-operative nature of copper binding
found in multiple repeats. Evidence from circular dichroism
indicates that the four octarepeats do not form isolated Cu2+
binding motifs, but rather fold up co-operatively within multiple
repeats,12 but the mechanism for this co-operative binding is still
unclear.
To date, crystallisation of Cu2+ bound multiple repeats has
been unsuccessful. Paramagnetic broadening of specific 1H NMR
signals indicates histidine co-ordination but the paramagnetic
Cu2+ ion makes structure determination by NMR difficult.11
However, a diamagnetic replacement ion for Cu2+ would facilitate
the use of NMR in structure determination. For this reason
we have used NMR and optical spectroscopy to investigate the
binding of other diamagnetic metal ions to the octarepeat region
of PrP. Early work on metal binding to PrP suggests that PrP
is quite specific for Cu2+ ions.44 However, Ni2+ ions are known
to form low-spin diamagnetic square-planar complexes and to
mimic type II Cu2+ binding.45,46 The metal ions; Pd2+, Pt2+ 47
and Au3+,48,49 are also good candidates as diamagnetic probes
of Cu2+ binding. Au3+ is known to form imidazole–Au3+ bridged
complexes at pH 6–748 and thus Au3+ is also a candidate as a probe
to investigate histidine bridging in PrP metal co-ordination, as
has been suggested to occur in the PrP octarepeat–Cu complex,11
although studies using EPR appear to rule out a bridged
species.
We have used HGGG, HGGGW, QPHGGGWGQ, PrP(2octa)
and PrP(4octa) peptides as models of the N-terminus octarepeat
metal binding domain of PrP. 1H NMR and optical spectroscopy
have been used to assess Ni2+, Pd2+, Pt2+ and Au3+ ions for their
suitability as a diamagnetic probe of Cu2+ binding. In particular
we have characterised the binding of Pd2+ to HGGG, HGGGW
and QPHGGGWGQ by 1H and 13C NMR spectroscopy. Under-
standing the structure of the Cu2+ bound octarepeats should give
us insight into the reasons for PrP’s specificity, affinity and folding
associated with Cu2+ binding.
Experimental
Peptide synthesis and purification
Peptides representing various lengths of the repeat region of
PrP were synthesised employing solid phase F-moc (N-(9-
fluorenyl)methoxycarbonyl) chemistry (A.B.C. Imperial College
London.) After removing from the resin and de-protection the
samples were purified using reverse-phase HPLC and charac-
terised using mass spectrometry and 1H NMR. In order to mimic
the peptides within the full-length prion protein all peptides
were blocked at the N-terminus with N-acetyl and at the C-
terminus with ethyl ester. Peptides synthesised included the
following from the human (PrP) sequence: HGGG; HGGGW;
PrP(1octa) QPHGGGWGQ; PrP(2octa, 73–91) WGQPHGGG-
WGQPHGGGWGQ; PrP(4octa, 58–91) QPHGGGWGQPHG-
GGWGQPHGGGWGQPHGGGWGQ.
Titration of metal ions
Peptide solution concentrations were measured using the extinc-
tion coefficient of tryptophan at 280 nm using the formula: n ×
5690 M−1cm−1 where n = the number of tryptophan residues
present.50 Typically, the freeze-dried peptides contained 5 to 10%
moisture by weight. Stock solutions, typically 50 mM, were
freshly prepared in D2O from: NiCl2·6H2O; K2[PdCl4] anhydrous;
K2[PtCl4] anhydrous; andNa[AuCl4]·2H2O. The addition of metal
ions to the octarepeat peptides was performed using small aliquots
of these stock solutions. The pH was measured both before and
after each spectrum was recorded. The uncorrected meter reading
in D2O is indicated as pH* throughout. Adjustments of pH were
made either by the addition of small aliquots of 10 mM NaOD,
and DCl or by the use of deuterated phosphate buffer, typically
20–50 mM.
Absorption spectroscopy (UV/Vis) and circular dichroism (CD)
UV/Vis electronic absorption spectra were obtained with a
Hitachi U-3010 double beam spectrophotometer using a 1 cm
path length. CD spectra were recorded on an AVIV instrument at
25 ◦C using a 0.1 cm path length cell for spectra recorded between
185 and 260 nm (far-UV region) and a 1 cm path-length cell for
data between 260 and 800 nm (near-UV and visible region) as
previously described.16,12
Nuclear magnetic resonance spectroscopy
NMR spectra were acquired on either a Bruker Avance 600 MHz
spectrometer equipped with a 5 mm triple resonance inverse-
detection triple-resonance (1H, 13C, 15N) z-gradient probe, or a
Bruker AMX 400 MHz spectrometer with a proton dedicated
5 mm probe. 2D homo-nuclear DQF-COSY, NOESY, TOCSY
andROESY (smixing = 300 ms) spectra were recorded with typically
4096 by 512 data points. Spectra were collected over 9216 Hz
(15 ppm) spectral widths in both dimensions. States-TPPI was
used for quadrature detection. Spectra were zero-filled to 2048 real
points in f1, and a p/2 shifted, squared sine-bell window function
applied prior toFourier transformation. The Pd–QPHGGGWGQ
spectra were acquired in 90%/10% H2O/D2O at 303 K. Water
suppression was achieved usingWATERGATE.51 1H spectra were
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referenced to the water peak.52 In addition, 13C-HSQC spectra
were acquired for thePd–QPHGGGWGQcomplex, 1mMpeptide
concentration was sufficient for natural abundancemeasurements.
Spectral widths of 14 ppm 1H by 100 ppm 13C were recorded with
2048 by 256 complex points. The spectra were transformed with a
squared cosine function. Data were processed using XWINNMR
(Bruker). ProtonNMRassignments were achieved using standard
homo-nuclear 2D methods.53
NMR structure calculations
Peak volumes in the ROESY spectra were classified as strong,
medium and weak, corresponding to upper bounds of 3.0 A˚, 5.0 A˚
and 6.0 A˚. Intensities were calibrated by comparison to intra-
residue ROEs between fixed proton distances of the tryptophan
ring. The lower distance boundary was set at 1.8 A˚ for all classes.
Pseudoatom corrections were applied where necessary. Stereo-
specific assignments forHisbb′ andTrpbb′ AMXsystemswere not
possible due to spectral overlap nor were Gly aa′ stereo-specific
assignments made. No metal-to-ligand restraints were assumed
for structure calculation.
Structures were determined using torsion angle dynamics with
simulated annealing in XPLOR.54 In the first step, an ab initio, tor-
sion angle dynamics protocol was used starting from an extended
conformation having randomφ andw angles. Fifty structureswere
produced after 45 ps of high temperature dynamics, followed by
cooling over 45 ps and, finally, 200 steps of energy minimisation.
Structures corresponding favourably to the experimental restraints
were refined by 3000 steps of Powell minimisation under the
influence of a full force field based on CHARM parameters.55 The
20 lowest energy structures were chosen to represent the solution
structure of Pd–QPHGGGWGQ. Acceptance criteria were no
NOE violation >0.5 A˚. Structural analysis was performed using
PROCHECK-NMR.56
Results
1H NMR monitored kinetics of Pd2+ binding to PrP octarepeat
fragments
The reaction of HGGGW with Pd2+ was monitored by 1D 1H
NMR, over a period of 12 hours, during which time spectra were
obtained at hourly intervals. Fig. 1 shows the evolution of 1H
NMR signals in the aromatic region after the addition of 0.5 mole
equivalent Pd2+ to HGGGW at pH* 8.5. Initially, overlapping
sets of new 1H NMR lines are seen and after 1 hour the proton
spectrum still has the appearance of multiple sets of overlapping
lines. Subsequent spectra show an increase in the intensity of a
number of resonances, accompanied by the diminution of other
signals and a reduction in complexity. After 12 hours two distinct
sets of lines of similar intensity are resolved. One set of lines
is assigned to apo HGGGW while the other set is assigned to
the Pd–HGGGW complex. The presence of two sets of NMR
signals indicates a slow-exchange complex on the NMR chemical-
shift time scale. Where individual lines are resolved there is
no significant change in half-height line-width between the apo
spectra and the Pd2+ loaded spectra. The ratio of the two sets of
resonances is approximately 1 : 1, at 0.5 mole equivalent Pd2+,
indicating the formation of a diamagnetic peptide–metal complex
Fig. 1 1HNMRmonitored reaction kinetics of Pd2+ binding toHGGGW.
1 mM HGGGW reacted with 0.5 mole equivalent of Pd2+ at pH* 8.5 in
D2O. Spectra were recorded at 400 MHz, 303 K at hourly intervals up to
12 hours. The aromatic region is shown. A final 1H NMR spectrum was
recorded after 1 week at 600 MHz. Signals for apo HGGGW (indicated
by *) and Pd2+ bound HGGGW are observed in a 1 : 1 ratio.
with 1 : 1 stoichiometry. In Fig. 1, the spectrum of Pd–HGGGW,
one week post Pd2+ ion addition, shows that the two sets of signals
have become still more distinct. It is clear from the 1H NMR
spectra that after addition of Pd2+ ions multiple species form
rapidly in ∼5 minutes or less and a single Pd–peptide complex
then evolves over a period of 24 hours.
The Pd–HGGGW reaction kinetics were also studied in a
phosphate buffered system at pH* 7.6 and similar behavior was
observed. Fig. 2 shows a comparison between the reaction kinetics
of the pH* 8.5 unbuffered and the pH* 7.6 phosphate-buffered
systems. The signal intensity of the resonances from the palladium
complex is shownplotted versus time. For this themean of the peak
heights of the histidine C4H and tryptophan C2H lines were used.
No significant difference is seen in reaction kinetics between pH*
7.6 and pH* 8.5 either with or without phosphate buffer. In both
cases the half-maximum signal is reached at ∼3 hours at 30 ◦C.
After 1 week the line widths at half-height of singlet NMR
signals from the Pd–HGGGW complex were typically 3.3 Hz.
These line widths are consistent with a monomeric Pd–HGGGW
species. Some precipitate was visible at this stage and so it is likely
This journal is © The Royal Society of Chemistry 2006 Dalton Trans., 2006, 509–518 | 511
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Fig. 2 1H NMR peak intensities monitored with time for Pd2+ binding to
HGGGW. HGGGW (1 mM) reacted with 0.5 mole equivalents of Pd2+ at
pH* 8.5, non-buffered (open box) or in 20mMdeuterated phosphate buffer
at pH* 7.6 (open circle). In each case the sum of the peak heights of the
histidine 4H and tryptophan 2H signals are plotted versus time post Pd2+
addition. The sum of the peak heights are normalized to 1.0 at maximal
intensity after 24 hours. The time taken to reach half-maximum signal is
shown as ∼3 hours under both conditions.
that some of the changes in the spectra reflect the removal from
solution of minor polymeric species due to precipitation.
Stoichiometry of Pd2+–PrP octarepeat complexes by 1H NMR
Fig. 3 shows the titration of separate samples of HGGGW with
varying amounts of Pd2+ at pH* 7.6 in phosphate buffer examined
by 1H NMR 24 hours post Pd2+ addition. Increasing addition of
Pd2+ causes a diminution of the apo HGGGW NMR signals and
the appearance of a new set of signals. Upon the addition of 1
mole equivalent Pd2+ only the NMR signals from the Pd2+ bound
form were observed, indicating tight binding at 1 mM peptide
concentrations.
Similar behavior was observed for the titration of HGGG with
Pd2+. Two sets of 1H NMR signals were produced for the apo and
Pd2+ bound peptide (data not shown) consistent with 1 : 1 peptide
metal complex formation. For example, the signals for the apo and
the Pd2+ bound species from the histidine resonances were of equal
intensity at 0.5 mole equivalent of Pd2+. At 1 mole equivalent of
Pd2+ there was only one set of signals for the Pd2+ bound His C2H
and His C4H resonances.
Fig. 4 shows the Pd2+ titration of QPHGGGWGQ. The
apopeptide signals decrease with Pd2+ addition, by one mole
equivalent of Pd2+ one major species is present. Fig. 5 shows the
intensities of a number of well resolved residues plotted versusPd2+
addition to QPHGGGWGQ. As the titration progresses beyond
1 mole equivalent Pd2+ the metal complex tryptophan C4H signal
becomes progressively diminished while, simultaneously, a new
doublet signal can be observed at 7.90 ppm. Similarly, the metal
complex histidine eH signal becomes progressively diminished as
the titration progresses beyond 1 mole equivalent Pd2+, while a
new line appears at 8.39 ppm. Thus, with the addition of 2 mole
equivalents of Pd2+ there are two Pd2+ complex species in evidence.
The second species becomes evenmore evident at higher additions
of Pd2+ suggesting an alternative-binding mode at elevated Pd2+
levels.
In summary, as with Cu2+ binding to HGGG, HGGGW and
QPHGGGWGQ,13,12 Pd2+ binds to the PrP fragments in a 1 : 1
Fig. 3 1H NMR spectrum of HGGGW titrated with Pd2+. Pd–HGGGW
samples were prepared 24 hours before spectra acquisition in 20 mM
deuterated phosphate buffer at pH* 7.6. Pd2+ additions are shown as mole
equivalents. 600MHz spectra were acquired at 303 K. The 0.2, 0.6 and 0.8
mole equivalent spectra are scaled by 2× relative to apo, and the 1.0 mol
equivalent Pd2+ spectrum scaled by 3× to allow for the loss of sample due
to precipitation with increasing Pd2+ additions.
ratio. This suggests that Pd2+ might be useful as a diamagnetic
mimic of Cu2+ binding.
1H and 13Ca NMR assignments and Pd2+ induced co-ordination
shifts
A suite of 1H homo-nuclear DQF-COSY, TOCSY, NOESY and
ROESY spectra were obtained for apo peptides and peptide–
Pd2+ complexes. Resonance assignments were made using the
standard homo-nuclear 2D methodology.53 Generally, the 2D
NOESY spectra produced a limited number of weak cross-peaks
for all three Pd bound peptides. The cross peaks obtained with the
peptides, HGGG and HGGGW, were of the opposite sign to the
diagonal, as is typical for small molecules, while QPHGGGWGQ
cross peaks gave the same sign as the diagonal. It was considered
likely that the correlation times of the peptides fall within the
range over which the NOE tends towards a null, between the small
molecule and macromolecular regimes. In contrast, the ROESY
spectrum of QPHGGGWGQ with 1 mole equivalent Pd2+ using
300 ms mixing time, gave a reasonable number of both intra- and
inter-residue ROEs. Fig. 6 shows TOCSY and ROESY spectra
for Pd–QPHGGGWGQ. Table 1 shows the 1H chemical shift
assignments of apo andPd2+ boundQPHGGGWGQ,HGGGand
HGGGW peptides. The apo peptide 1H resonance assignments
at pH* 7.6 are close to the values published for random coil
512 | Dalton Trans., 2006, 509–518 This journal is © The Royal Society of Chemistry 2006
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Fig. 4 1H NMR spectrum of QPHGGGWGQ titrated with Pd2+.
Pd–QPHGGGWGQ samples (1 mM, 20 mMdeuterated phosphate buffer
at pH* 7.6) were prepared 24 hours prior to acquisition. Pd2+ additions
are shown as mole equivalents. 400 MHz spectra were acquired at 303 K.
resonances.53 In addition, a natural abundance 1H–13C HSQC
spectrum was used to obtain 13C Ca co-ordination shifts upon
Pd2+ binding to QPHGGGWGQ, presented in Table 2.
The TOCSY spectrum (in 90% H2O) shown in Fig. 6 indicates
that amide protons (NH–aH connectivities) are observable for
Glu1, His3, and Trp7 to Glu9 but Gly5 and Gly6 amide main
chain protons are not observed in the Pd2+ bound proton TOCSY
spectra. Metal co-ordination to main-chain nitrogens is expected
to displace the amide protons, hence their absence suggests that
Pd2+ is bound to the Gly5 and Gly6 amide nitrogens.
Fig. 5 Pd2+ binding curves for QPHGGGWGQ. 1H NMR absolute
peak heights are taken from data presented in Fig. 4. Peak assignments
as follows: (A) Histidine 2H; (e) apo peptide; (B) major Pd2+ complex
tryptophan 2H; (C) major Pd2+ complex Trp 4H; (D) minor Pd2+ complex
His 2H; (E) minor Pd2+ complex Trp 4H.
Chemical shift changes upon Pd2+ co-ordination can indicate
the ligands directly involved in co-ordination to the metal ion,
although indirect effects from the ring-current of Trp or His
rings may also cause significant changes in chemical shift upon
metal chelation. 13Ca co-ordination shifts on Pd2+ binding are
presented in Table 2. Upon Pd2+ co-ordination all residues, with
the exception of the two glutamine residues (which are outside of
the binding motif), display high-field shifts of the Ca resonances.
Themost significantCahigh-field shifts are those ofGly5 andGly6
(17.7 and 10.7 ppm respectively). The high-field shift of these Ca
resonances suggests that Pd2+ co-ordination occurs to the adjacent
amide nitrogen of these residues. This assertion is supported by
the observed displacement of the Gly5 and Gly6 amide protons
upon Pd2+ co-ordination.
The changes in 1H NMR chemical shifts upon co-ordination of
Pd2+ may be compared to those observed for other square-planar
Pd2+ complexes such as Gly-Gly-His49 for which there is a crystal
structure. Chemical shifts for the Pd2+ bound imidazole 2H (e)
and 4H (d) protons of 7.62 ppm and 6.96 ppm, reported here for
Pd–HGGG (Table 1), are very similar to those reported for the
square-planar Pd2+ complex of GGH, 7.60 ppm and 6.97 ppm
respectively.49 However, Pd2+ co-ordinates to the dN in the crystal
structure of Pd-GlyGlyHis while we show Pd2+ co-ordination
is most likely to be to the eN in the octarepeat complex. Co-
ordination shifts to high-field are typically observed for the a
protons of residues in which the main-chain amide co-ordinates
the metal ion. For example, the Pd–GGH complex produces
co-ordination shifts for a protons of −0.23; −0.09; −0.19 ppm
respectively,49 see also ref. 57. Similarly, Ha protons in HGGG
exhibit high-field shifts upon Pd2+ co-ordination. However, the
Pd2+ co-ordination shifts are relatively small and could be, for
example, masked by quite modest ring-current effects. For this
reason, inferences about co-ordinating ligands in Pd2+ complexes
based on chemical shifts alone many not be valid.
Table 3 compares the Pd2+ bound 1H chemical shifts forHGGG,
HGGGW and QPHGGGWGQ in order to investigate the effect
of the presence of tryptophan on the Pd–HGGG complex. In
general, the differences between HGGGW and QPHGGGWGQ
are small, for example the difference in chemical shift for the His
This journal is © The Royal Society of Chemistry 2006 Dalton Trans., 2006, 509–518 | 513
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Table 1 1H Chemical shift (ppm) for apo and Pd2+ bound octarepeat peptide fragments. Data for three peptide fragments are shown, QPHGGGWGQ,
HGGGW and HGGG. The difference in chemical shift between apo and Pd2+ peptide is also indicated
QPHGGGWGQ HGGGW HGGG
Residue Apo Pd bound d Pd − d apo Apo Pd bound d Pd − d apo Apo Pd bound d Pd − d apo
Q1 NH 8.23 8.30 +0.07
a 4.61 4.61 0.00
b 2.04 1.97 −0.07
b′ 1.86 2.15 +0.29
c 2.36 2.45 +0.09
c′ 2.36 2.45 +0.09
P2 a 4.37 4.27 −0.10
b 2.22 2.21 −0.01
b′ 1.92 1.92 0.00
c 1.79 1.98 +0.19
c′ 1.79 1.98 +0.19
d 3.75 3.78 +0.03
d′ 3.59 3.65 +0.06
H3 NH 8.42 7.69 −0.73
a 4.56 4.25 −0.31 4.56 4.26 −0.30 4.63 4.48 −0.15
b 3.15 2.6 −0.55 3.08 2.51 −0.57 3.10 3.56 +0.46
b′ 3.10 2.6 −0.50 3.00 2.30 −0.70 3.05 3.11 +0.06
2H(e) 8.12 7.49 −0.63 7.74 7.58 −0.16 7.80 7.62 −0.18
4H(d) 7.07 6.96 −0.11 6.96 6.81 −0.15 7.03 6.96 −0.07
G4 NH 8.28 7.66 0.62 # # # # # #
a 4.01 3.99 # 3.87 4.10 # 4.03 4.21 #
a′ 3.87 3.87 # 3.71 3.77 # 3.93 3.94 #
G5 NH 8.28 n/a n/a
a 4.01 4.10 # 3.87 4.01 # 4.03 4.01 #
a′ 3.87 3.78 # 3.71 3.69 # 3.93 3.84 #
G6 NH 8.28 n/a n/a
a 4.01 4.05 # 3.87 3.84 # 4.03 3.78 #
a′ 3.87 3.81 # 3.71 3.34 # 3.93 3.54 #
W7 NH 8.05 7.84 # # # #
a 4.66 4.55 −0.11 4.64 4.50 −0.14
b 3.32 3.43 +0.11 3.33 3.49 −0.16
b′ 3.24 3.35 +0.13 3.21 2.39 +0.18
2H 7.24 7.35 +0.11 7.24 7.36 +0.12
4H 7.62 7.70 +0.08 7.77 7.71 −0.06
5H 7.15 7.18 +0.03 7.16 7.18 +0.02
6H 7.23 7.21 −0.02 7.24 7.23 −0.01
7H 7.48 7.46 −0.02 7.50 7.53 +0.03
G8 NH 8.30 8.49 +0.19
a 3.87 4.21 +0.34
a′ 3.78 3.71 −0.07
Q9 NH 8.03 8.10 +0.07
a 4.27 4.29 +0.02
b 2.15 1.97 −0.18
b′ 1.92 2.18 +0.26
c 2.34 2.31 −0.03
c′ 2.34 2.31 −0.03
Table 2 13Ca chemical shifts for apo and Pd2+ bound QPHGGGWGQ
octarepeat. Chemical shifts are in ppm. The difference in chemical shift
upon Pd2+ co-ordination is also indicated
13Ca apo 13Ca Pd2+ 13Ca Difference
Q1
P2 61.5 63.2 +1.7
H3 52.0 57.0 +5.0
G4 43.3 44.5 +1.2
G5 43.3 61.0 +17.7
G6 43.3 54.0 +10.7
W7 56.5 57.0 +0.5
G8 42.0 44.6 +2.6
Q9 54.6 53.0 +1.6
Ha resonance between Pd–QPHGGGWGQ and Pd–HGGGW
is only −0.01 ppm. Similarly the Trp resonances are largely
unaffected, suggesting that the presence of the other residues
present in QPHGGGWGQ have little effect on the co-ordination
geometry. In contrast, the difference in His Ha and Hb chemical
shifts between Pd–HGGG and Pd–HGGGW are relatively large;
−0.22 ppm, (His Ha) −0.60 ppm and −1.26 ppm (His Hbb′). The
inclusion of the Trp side chain in HGGGW causes a pronounced
high-field shift of the His Ha and Hb resonances, presumably due
to the ring current effects caused by the close proximity of the ring
face of the tryptophan.
NMR solution structure of Pd2+–QPHGGGWGQ
Analysis of the Pd2+ loaded 300 ms ROESY spectrum yielded a
total of 71 distance restraints used in the structural calculations.Of
these, 21 aremedium or long-range restraints, and are summarised
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Fig. 6 2D TOCSY and ROESY NMR spectra for Pd–QPHGGGWGQ
complex. Assigned resonances are labeled in both the TOCSY spectrum
(A) and the corresponding 1D spectrum. The ROESY spectrum (B),
shows that a number of sequential and longer range ROE cross peaks
are observed. Both are 600 MHz spectra recorded at 303 K, pH 6.5 in
90%/10% H2O/D2O, at 1 mM peptide concentration.
in Table 4. Metal-to-ligand restraints were not used for structure
calculation in order not to pre-judge the co-ordination geometry.
ROEs between the proline, tryptophan and histidine dominate the
restraint file. Pro2 was determined to be in the trans configuration
with a strong Hd Pro2 to Ha Glu1 ROE cross-peak. Structures
were obtained using restrained molecular dynamics. The lowest
energy conformers chosen to represent the structure of Pd–
QPHGGGWGQ have an average RMSD (with respect to the
mean structure) over all residues (Q1–Q9) of 0.58 A˚ for the main-
chain and 0.97 A˚ for all heavy atoms. Procheck-NMR was used
to analyse the structures56 and it was found that all residues lie
in the most favoured and allowed regions of the Ramachandran
plot. The structural statistics are given in Table 4. None of the
structures had NOE violations > 0.2 A˚. Fig. 7 shows the family of
conformers describing the solution structure of QPHGGGWGQ
with Pd2+ bound.
Table 3 A comparison of 1H NMR chemical shift for Pd–HGGG, Pd–
HGGGW and Pd–QPHGGGWGQ. Difference in chemical shift (in ppm)
between Pd–HGGGWand Pd–HGGGand also chemical shift differences
between Pd–QPHGGGWGQ and Pd–HGGGWare shown. Only His and
Trp resonances are shown due to a lack of stereo-specific assignments for
glycine resonances
Resonance HGGGW–HGGG (ppm)
QPHGGGWGQ–HGGGW
(ppm)
Histidine
Ha −0.22 −0.01
Hb −0.60 +0.09
Hb′ −1.26 +0.30
2H(e) −0.04 −0.09
4H(d) −0.15 +0.15
Tryptophan
Ha a +0.02
Hb a +0.03
Hb′ a +0.02
2H a +0.01
4H a +0.03
5H a 0.00
6H a +0.01
7H a +0.02
a Not applicable.
It is clear from the ensemble that Pd2+ chelation causes themain-
chain to form an ordered loop around the metal ion. In particular
the Pd2+ co-ordinating residues, HGGGW, give aRMSDof 0.30 A˚
for the main-chain. Once the family of structures was obtained the
probable position of the Pd2+ ion was modeled into the loop that
contains residues HGGGW. Typical palladium to nitrogen (or
oxygen) bond lengths for a square-planar complex are 2.0 A˚.49
Only Pd2+ co-ordination to the His3 side chain Ne, Gly5 amide
N and Gly6 amide N, produced a complex that did not violate
any of the ROEs, and retained the conformation determined in
the absence of metal restraints. In particular, the relative position
of the imidazole ring to other potential ligands did not lend itself
to co-ordination of Pd2+ to the His d nitrogen. The identity of the
fourth ligand is not readily apparent from the family of structures
suggesting water as a fourth ligand. A possible alterative candidate
is the Trp amide, however this appears to be too distant. The Gly6
carbonyl oxygen appears to be ruled out on the grounds of bond
angle geometry.
Obtaining a well-defined NMR structure for this small peptide
is fraught with difficulties. The number of long-range distance
restraints is limited in a 9-residue peptide. The presence of four
glycine residues and the loss of amide protons due to metal co-
ordination reduce the number of observable NOEs still further.
Despite these difficulties His Ne, Gly5 Na and Gly6 Na are the
only set of co-ordinating ligands that can be incorporated into
the solution structure without significant rearrangement of the
structure and the introduction of a number of ROE violations.
In addition, the determined solution structure, and the inferred
position of the Pd2+ ion, is consistent with the loss of main-chain
amide protons observed for Gly5 and Gly6 upon Pd2+ addition.
Furthermore, the 13Ca co-ordination shift data also suggest that
QPHGGGWGQ co-ordinates the Pd2+ ion by the histidine side-
chain and two glycine residues; Gly5 andGly6. Finally, the relative
orientation of the tryptophan side-chain, in the proposed solution
structure, is consistent with the 1H co-ordination shifts (Table 3).
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Table 4 Structural and energy statistics for Pd2+ loaded QPHGGGWGQ
(A) Experimental constraintsa
Intra-residue distance 20
Sequential distances (|i–j| = 1) 30
Medium range distances (|i–j| = < 5) 13
Long range distance (|i–j| = > 5) 8
Dihedral angles 0
(B) Constraint violations
Number of NOE violations > 0.2 A˚ 0
Maximum NOE violation/A˚ 0.196
(C) RMS deviation from experimental constraints
NOE/A˚ 3.3 × 10−2 ± 6.59 × 10−3
(D) RMS deviation from idealised geometry
Bonds/A˚ 4.14 × 10−3 ± 2.32 × 10−4
Angles/◦ 6.65 × 10−1 ± 2.55 × 10−2
Impropers/◦ 3.08 × 10−1 ± 1.59 × 10−2
(E) Energiesb/kcal mol−1
E(NOE) 1.72 ± 0.66
E(Van der Waals) −17.01 ± 3.49
E(total) 2.88 ± 4.15
(F) RMS to the average co-ordinates/A˚
Backbone (N, Ca, C) (1–9)c 0.58
Backbone (N, Ca, C) (3–7)c 0.30
Heavy atoms (1–9)c 0.97
Heavy atoms (3–7)c 0.59
(G) Ramachandran analysis (1–9)c (%)
Residues in disallowed regions 0
Residues in generously allowed regions 0
Residues in allowed regions 52.9
Residues in most favourable regions 47.1
a Pd2+ to ligand restraints have not been used in structure calculations. b Energy calculated with the CHARM M19 empirical energy function. c Residues
included in analysis are indicated in parentheses.
In particular, the Trp indole ring is orientated face-on to the His b
protons, thus accounting for the large (−1.26 ppmand−0.60 ppm)
high-field co-ordination shifts observed.
Despite the success in obtaining 1H NMR spectra with Pd2+
bound to a single octarepeat, suitable for solution structure deter-
mination, attempts to obtain usable 1H NMR spectra of multiple
octarepeats bound toPd2+ have, to date, been unsuccessful. The ad-
dition of various amounts of Pd2+, to the two and four octarepeat
fragment, over a range of concentrations and pH values, caused
immediate turbidity and precipitation. Only broad 1H NMR
signals, characteristic of polymerised species, were observed.
Ni2+, Pt2+ and Au3+ will not form a square-planar complex with the
octarepeats
Ni2+ is often a good replacement ion for square-planar type II
Cu2+ binding. For example, Ni2+ binding to the Cu2+ binding
site of serum albumin57,46 and more recently to the amyloidgenic
region of PrP, centered at residues His111 and His96,16 have been
reported. 1H NMR spectra of HGGGW loaded with increasing
amounts ofNi2+ were obtained.However, surprisingly therewas no
evidence of a low-spin, diamagnetic, square-planar Ni2+ complex.
Neither were shifts in resonances observed, that would imply a
diamagnetic complex in fast exchange. Instead the incremental
addition of Ni2+ ions caused increased broadening of all the
NMRsignals present, suggesting the formation of a paramagnetic,
high spin, tetrahedral or octahedral complex. Similar observations
were made with the two octarepeat peptide, PrP(2octa). Although
various mole equivalents of Ni2+ were studied over a range of
pH values (between pH 6 to 11) no evidence of the formation
of a diamagnetic Ni-complex species was observed. Furthermore,
in agreement with the 1H NMR data, d–d absorption bands or
visible CD bands between 420–450 nm, characteristic of a Ni2+
square-planar complex,45,16,47 were not observed.
Like Ni2+, Pt2+ can replace Cu2+ to form square-planar com-
plexes. Proton NMR spectra were obtained for HGGGW titrated
with PtCl2. The addition of increasing amounts of Pt2+ caused
progressive broadening of histidine 2H (e) and 4H (d) resonances
(data not shown). Again there was no observation of 1HNMR res-
onances that would indicate a monomeric Pt–HGGGW complex
in slow-exchange.
Au3+ is known to form complexes with square-planar
geometry.49 Additions of Au3+ were monitored by absorption
spectroscopy. An absorption band at 520 nm was observed to
evolve with Au3+ addition. The observation of a strong purple
colour on the addition of Au3+ to the peptide could be mis-
interpreted as the formationof anAu3+–peptide complex.However
it is clear that the band at 520 nm is due to the presence of
colloidal Au(0) rather than Au–HGGGW complex formation.
Au(0) colloids have previously been reported to produce a band
around 520 nm depending on particle size.58 Reduction of Au3+ in
solutions exposed to ambient light has been reported and ligand
oxidation has been reported in the reaction of NH3–Gly–Gly–His
with Au3+.49 For these reasons it was concluded that Au3+ would
not be of use as a probe of Cu2+ binding to the octarepeats.
Discussion
There are relatively few reports of Pd2+ peptide complexes, however
Pd2+ can substitute for Cu2+ in square-planar complexes. For
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Fig. 7 Solution structure of Pd2+ bound QPHGGGWGQ. An ensemble
of the lowest energy backbone conformers. The backbone ensemble is also
shown rotated by 90◦. Structures are calculated without the use of Pd to
ligand restraints. The most plausible co-ordination of the Pd2+ ion is to the
His3 Nd, Gly5 Na and Gly6 Na. Pd2+ chelation causes the peptide to form
a loop conformation around the metal ion. Main-chain RMSD for the
metal binding motif, Pd–HGGGW, is 0.30 A˚.
example, Pd2+ is square-planar when bound to Gly-Gly-His49 and
to Gly-His-Lys.59 Here, 1H NMR investigations have shown that
Pd2+ will also bind to HGGG, HGGGW and QPHGGGWGQ,
forming 1 : 1 diamagnetic complexes in slow-exchange on the
NMR timescale, between free and Pd2+ bound peptide. The
formation of the Pd2+ complexes is slow reaching half maximal
signal only after ∼3 hours. The end-point complexes are stable at
25 ◦C over a number of weeks. The relatively slow formation of
the palladium complex is not unprecedented, similar kinetics have
been reported for the formation ofNi2+, Pd2+ and Pt2+ complexes.47
The reaction of Pd2+ with Gly-His-Lys has been shown to proceed
to a single product over 10 hours59 and a similar time scale has
been reported for the reaction ofGly-Gly-His with Pd2+.49 The rate
limiting step in the formation of the Pd–HGGGW complex may
be the ionisation of amide hydrogen atoms, as has been observed
for Ni2+–peptide complexes.47
Although Pd2+ forms a square-planar complex with the single
octarepeat peptide it is apparent from the NMR structure that
the co-ordination geometry is not the same as found in the Cu2+
bound HGGGW crystal structure.14 In the crystal structure Cu2+
is co-ordinated by the His3 side chain Nd, Gly4 amide N andGly5
amide N and carbonyl O of Gly5. An axially co-ordinated water
molecule is also observed.14 In contrast, the most probable ligands
for the Pd2+ co-ordination, based on the NMR data, include the
His3 side chainNe, Gly5 amide nitrogen andGly6 amide nitrogen.
The Cu2+ complex forms a sevenmembered ring betweenGly 4Ha
and His Ndand it is possible that this configuration is too strained
with the inclusion of the Pd2+ ion, forcing the very different Pd2+
co-ordination observed.
Ni2+ often forms diamagnetic, low-spin, square-planar com-
plexes with histidine containing peptides.47,16 Surprisingly in the
case of the PrP ocatrepeats no such Ni2+ complex is formed.
Cu2+ and Ni2+ ions have the ability to co-ordinate to histidine
imidazole nitrogens. Using the histidine as an ‘anchor’, Cu2+ and
Ni2+ ions are capable of deprotonating neighbouring amide main-
chain nitrogens in unstructured regions of proteins.47 Cu2+ can
do this at physiological pH values, but Ni2+ requires elevated
pH’s (between pH 8 and 9) to achieve deprotonation of main-
chain amides. This has been observed for Ni2+ binding to His96
and His111 in the unstructured amyloidogenic region of PrPC.16
However, Ni2+ co-ordination in a square-planar geometry to the
octarepeat peptide does not take place even at elevated pH values.
Both Cu2+ and Ni2+ prefer to co-ordinate to amide nitrogen atoms
that are to the N-terminus of the histidine residues. This results in
the formation of a more stable six membered chelate ring with the
His dN and the main-chain aN of the histidine. Co-ordination of
amides to the C-terminus of the histidine imidazole ring results in
a less stable seven membered ring. In the case of the octarepeats,
N-terminal co-ordination is not possible due to the presence of
a proline preceding the His residue. It is perhaps the presence of
proline that precludes the formation of a square-planar complex
of Ni2+, Pt2+ or Au3+ with the octarepeats, giving this region of the
prion protein its specificity for Cu2+ ions.
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